I. Tadeo

发表

Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma

D. Montaner, S. Navarro, I. Tadeo, 2014, Pediatric Research.

Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy

Luis M. Escudero, I. Tadeo, A. Berbegall, 2014, Front. Oncol..

Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview.

I. Tadeo, R. Noguera, T. Álvaro, 2012, Histology and histopathology.

Tumor Microenvironment Heterogeneity: A Review of the Biology Masterpiece, Evaluation Systems, and Therapeutic Implications

S. Navarro, I. Tadeo, R. Noguera, 2016 .

Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging

I. Tadeo, R. Noguera, L. Lovergne, 2014, Analytical and Bioanalytical Chemistry.

Lymph microvascularization as a prognostic indicator in neuroblastoma

F. Ritort, G. Bueno, S. Navarro, 2018, Oncotarget.

Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors

G. Bueno, M. Fernández-Carrobles, M. García-Rojo, 2016, Oncotarget.

Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort

S. Navarro, I. Tadeo, A. Berbegall, 2016, British Journal of Cancer.

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration1

S. Navarro, I. Tadeo, E. Villamón, 2014, Neoplasia.

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours

D. Gisselsson, S. Navarro, I. Tadeo, 2014, International journal of cancer.

Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

P. Ambros, S. Navarro, I. Tadeo, 2016, Oncogene.

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion

S. Navarro, I. Tadeo, M. Piqueras, 2013, PloS one.

Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors.

S. Navarro, A. Berthier, I. Tadeo, 2011, Human pathology.

Comparative study of MLPA-FISH to determine DNA copy number alterations in neuroblastic tumors.

S. Navarro, I. Tadeo, M. Piqueras, 2011, Histology and histopathology.

Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.

D. Gisselsson, S. Navarro, I. Øra, 2016, Cancer letters.

1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors.

S. Navarro, I. Tadeo, A. Berbegall, 2018, Histology and histopathology.

A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors

S. Navarro, I. Tadeo, A. Berbegall, 2017, Pediatric blood & cancer.

NeuPAT: An intranet database supporting translational research in neuroblastic tumors

Vicente Hernández, Ignacio Blanquer, Eva Villamón, 2013, Comput. Biol. Medicine.

Gain of MYCN Region in a Wilms Tumor-derived Xenotransplanted Cell Line

A. Llombart‐Bosch, S. Navarro, I. Tadeo, 2010, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Tumor Microenvironment Heterogeneity: A Review of the Biology Masterpiece, Evaluation Systems, and Therapeutic Implications

S. Navarro, I. Tadeo, R. Noguera, 2016 .

TMA Vessel Segmentation Based on Color and Morphological Features: Application to Angiogenesis Research

Marcial García-Rojo, Oscar Déniz, Gloria Bueno, 2013, TheScientificWorldJournal.

A morphometric tool applied to angiogenesis research based on vessel segmentation

Marcial García-Rojo, Oscar Déniz, Gloria Bueno, 2013, Diagnostic Pathology.

NeuPAT: An intranet database supporting translational research in neuroblastic tumors

Fco. Javier Meseguer Anastásio, I. Blanquer, V. Hernández, 2013, Comput. Biol. Medicine.